FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients
NCT: NCT07385599 · RECRUITING
NCT IDNCT07385599
StatusRECRUITING
Start Date2026-01-19
Completion2028-03-01
SponsorLifetech Scientific (Shenzhen) Co., Ltd. (INDUSTRY)
First posted
Last updated
Brief Summary
To evaluate the preliminary safety and feasibility of the LAmbreTM II Left Atrial Appendage Occluder and the Occluder Delivery System in patients with non-valvular atrial fibrillation who are at increased risk for stroke and systemic embolism.
Frequently Asked Questions
What is FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients?
FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients is a clinical trial registered under NCT07385599. Current status: RECRUITING.
What is the status of NCT07385599?
The current status of NCT07385599 (FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients) is: RECRUITING.
When did FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients start?
FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients started on 2026-01-19.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.